PARSIPPANY, N.J., Oct. 21, 2011 /PRNewswire/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI) today announced that the U.S. Food and Drug Administration (FDA) approved its Androderm® (testosterone ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results